RecruitingNCT05951088

Long-term Evaluation of a Mobile Application for Follow-up of Cardiac Patients

Sponsor: University Hospital, Antwerp

Trial Details

Condition	Follow-up, Education, Mobile Health
Intervention	Cardio2U follow-up
Status	Recruiting
Participants	200
Est. Completion	30 May 2026
Last Updated	8 May 2026

Primary Outcome

Usability of the application; Patient satisfaction with the application-driven follow-up; Long-term adherence

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: 1. Age ≥ 18 years, 2. Patients in whom AF or atrial flutter is diagnosed with an electrocardiogram (12-lead, Holter monitor,…) and/or patients in whom HF is diagnosed in their medical records, 3. Patients who are capable of signing the informed consent. Exclusion Criteria: 1. Not able to speak and read Dutch, 2. Cognitive impaired (e.g. severe dementia), 3. No smartphone or tablet available.

Trial Sites

Countries

Belgium

View Registry Entry

Related Analysis

Belgian Mobile Health Trial Tests Cardio2U App for Atrial Fibrillation and Heart Failure Follow-up — Digital Care Revolution Under Study

Belgian researchers are testing the Cardio2U mobile application for long-term follow-up of patients with atrial fibrillation and heart failure. This 200-participant study evaluates usability, patient satisfaction, and adherence to app-driven cardiac care through 2026.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service